Marker Therapeutics Inc (MRKR)

[Phantom Lord]

The most logical thing I can think of that makes sense is that it's volume coming in prior to the JP Morgan conference the second week in January. I don't think we hear much from their presentation, nor do I think the topic warrants much volume but I do expect to hear something on their clinical updates.

It could also just be that the market cap is so small it's finally going up to a more reasonable level.